Protecting the Right to Enjoy Doping-Free Sport


UK Anti-Doping and TICTAC sign agreement to develop anti-doping understanding

UK Anti-Doping and drug identification specialists TICTAC have signed an agreement to work together to help improve awareness of prohibited substances and assist in the fight against doping in sport.

TICTAC is a comprehensive information system for the visual identification of solid dose drugs. It is widely used within the healthcare and law enforcement sectors, where more than 75,000 professionals have access to it.

UK Anti-Doping has entered into a contract with TICTAC – which is based at St George’s, University of London – to place a visual marker on those substances on the TICTAC database which are included in the Prohibited List, published annually by the World Anti-Doping Agency. These markers will raise awareness of these substances to those using the TICTAC system, who will in turn generate information to allow UK Anti-Doping to understand the availability of these substances in the UK. This agreement will help develop relationships and sources to understand the landscape of doping substances being used in the UK.

UK Anti-Doping Chief Executive Andy Parkinson said: “UK Anti-Doping is delighted to work with TICTAC in developing a comprehensive anti-doping element to their database. Establishing formal partnerships with external agencies is vital in our ability to tackle the supply of doping related substances and intensify our activities in the global fight against doping in sport.

“This latest agreement should further reinforce the message to those who are considering trafficking or supplying doping substances, that the net is closing in and we are doing all we can to protect the rights of athletes to compete in doping-free sport.”

TICTAC director John Ramsey, a toxicologist at St George’s, said: “The addition of drugs which are prohibited in sport will provide a further benefit to TICTAC’s clients. We are pleased to be working with UK Anti-Doping to assist with the elimination of doping in sport.”

Notes to Editors:

UK Anti-Doping
UK Anti-Doping is the National Anti-Doping Organisation for the UK.  
UK Anti-Doping has responsibility for ensuring sports bodies in the UK are compliant with the World Anti-Doping Code through implementation and management of the UK’s National Anti-Doping Policy.
UK Anti-Doping’s functions include an education and information programme, athlete testing across more than 40 sports, intelligence management and exclusive results management authority for the determination of anti-doping rule violations.
Accountable to the Department for Culture, Media and Sport (DCMS), UK Anti-Doping has a very clear remit in anti-doping in the UK and plays a lead role in the fight against doping in sport.

The TICTAC system incorporates a comprehensive drugs database (currently 27,300 drugs/medicines) into a user friendly software package. Together, this provides instant visual identification of solid dose drugs.  TICTAC is produced by TICTAC Communications Ltd., a company which specialises in the identification and analysis of new and emerging drugs.
TICTAC Communications is based at St George’s, University of London.

About St George’s, University of London:
St George’s, University of London (SGUL), established in 1733, is distinctive as the UK’s only independent medical and healthcare higher education institution. It benefits from strong links with the healthcare profession, including a shared site with St George’s Healthcare NHS Trust in Tooting, south west London.
SGUL is dedicated to the education and training of doctors, nurses, midwives, physician’s assistants, paramedics, physiotherapists, radiographers, social workers, healthcare and biomedical scientists. It attracts around 6,000 students, some of whom are taught in conjunction with Kingston University.
Research at SGUL has a UK and international focus and aims to improve prevention, diagnosis and treatment of disease in areas including infection and immunity, heart disease and stroke, and cell signalling. It also aims to enhance understanding of public health and epidemiology, clinical genetics, and social care sciences.